Selected research
Industry Research
Propofol Medium/Long Chain Fat Emulsion Injection Industry Research Report 2026
Market perspective
The global Propofol Medium/Long Chain Fat Emulsion Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Propofol Medium/Long Chain Fat Emulsion Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Propofol Medium/Long Chain Fat Emulsion Injection market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Propofol Medium/Long Chain Fat Emulsion Injection market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Propofol Medium/Long Chain Fat Emulsion Injection include Pfizer, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi Deutschland GmbH, Centurion Healthcare Private Limited and B.Braun Melsungen AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Propofol Medium/Long Chain Fat Emulsion Injection market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Propofol Medium/Long Chain Fat Emulsion Injection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propofol Medium/Long Chain Fat Emulsion Injection Market by Company
Pfizer
AstraZeneca
Wellona Pharma
Rusoma Laboratories
Neon Laboratories Limited
Fresenius Kabi Deutschland GmbH
Centurion Healthcare Private Limited
B.Braun Melsungen AG
Propofol Medium/Long Chain Fat Emulsion Injection Segment by Type
10ml：0.1g
20ml：0.2g
50ml：0.5g
100ml：1.0g
Others
Propofol Medium/Long Chain Fat Emulsion Injection Segment by Application
Hospital
Clinic
Others
Propofol Medium/Long Chain Fat Emulsion Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Medium/Long Chain Fat Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Medium/Long Chain Fat Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Medium/Long Chain Fat Emulsion Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Propofol Medium/Long Chain Fat Emulsion Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ml：0.1g
- 20ml：0.2g
- 50ml：0.5g
- 100ml：1.0g
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Pfizer
- AstraZeneca
- Wellona Pharma
- Rusoma Laboratories
- Neon Laboratories Limited
- Fresenius Kabi Deutschland GmbH
- Centurion Healthcare Private Limited
- B.Braun Melsungen AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Propofol Medium/Long Chain Fat Emulsion Injection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 10ml：0.1g
- 2.2.3 20ml：0.2g
- 2.2.4 50ml：0.5g
- 2.2.5 100ml：1.0g
- 2.2.6 Others
- 2.3 Propofol Medium/Long Chain Fat Emulsion Injection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Propofol Medium/Long Chain Fat Emulsion Injection Breakdown Data by Type
- 3.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Historic Market Size by Type (2021-2026)
- 3.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Forecasted Market Size by Type (2027-2032)
4 Propofol Medium/Long Chain Fat Emulsion Injection Breakdown Data by Application
- 4.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Historic Market Size by Application (2021-2026)
- 4.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Perspective (2021-2032)
- 5.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Growth Trends by Region
- 5.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Propofol Medium/Long Chain Fat Emulsion Injection Historic Market Size by Region (2021-2026)
- 5.2.3 Propofol Medium/Long Chain Fat Emulsion Injection Forecasted Market Size by Region (2027-2032)
- 5.3 Propofol Medium/Long Chain Fat Emulsion Injection Market Dynamics
- 5.3.1 Propofol Medium/Long Chain Fat Emulsion Injection Industry Trends
- 5.3.2 Propofol Medium/Long Chain Fat Emulsion Injection Market Drivers
- 5.3.3 Propofol Medium/Long Chain Fat Emulsion Injection Market Challenges
- 5.3.4 Propofol Medium/Long Chain Fat Emulsion Injection Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Propofol Medium/Long Chain Fat Emulsion Injection Players by Revenue
- 6.1.1 Global Top Propofol Medium/Long Chain Fat Emulsion Injection Players by Revenue (2021-2026)
- 6.1.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Players (2021-2026)
- 6.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Propofol Medium/Long Chain Fat Emulsion Injection Head Office and Area Served
- 6.4 Global Propofol Medium/Long Chain Fat Emulsion Injection Players, Product Type & Application
- 6.5 Global Propofol Medium/Long Chain Fat Emulsion Injection Manufacturers Established Date
- 6.6 Global Propofol Medium/Long Chain Fat Emulsion Injection Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
- 7.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2021-2026)
- 7.4 North America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
- 8.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2021-2026)
- 8.4 Europe Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
- 9.2 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
- 10.2 South America Propofol Medium/Long Chain Fat Emulsion Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2021-2026)
- 10.4 South America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
- 11.2 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer
- 12.1.1 Pfizer Company Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.1.4 Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.1.5 Pfizer Recent Developments
- 12.2 AstraZeneca
- 12.2.1 AstraZeneca Company Information
- 12.2.2 AstraZeneca Business Overview
- 12.2.3 AstraZeneca Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.2.4 AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.2.5 AstraZeneca Recent Developments
- 12.3 Wellona Pharma
- 12.3.1 Wellona Pharma Company Information
- 12.3.2 Wellona Pharma Business Overview
- 12.3.3 Wellona Pharma Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.3.4 Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.3.5 Wellona Pharma Recent Developments
- 12.4 Rusoma Laboratories
- 12.4.1 Rusoma Laboratories Company Information
- 12.4.2 Rusoma Laboratories Business Overview
- 12.4.3 Rusoma Laboratories Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.4.4 Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.4.5 Rusoma Laboratories Recent Developments
- 12.5 Neon Laboratories Limited
- 12.5.1 Neon Laboratories Limited Company Information
- 12.5.2 Neon Laboratories Limited Business Overview
- 12.5.3 Neon Laboratories Limited Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.5.4 Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.5.5 Neon Laboratories Limited Recent Developments
- 12.6 Fresenius Kabi Deutschland GmbH
- 12.6.1 Fresenius Kabi Deutschland GmbH Company Information
- 12.6.2 Fresenius Kabi Deutschland GmbH Business Overview
- 12.6.3 Fresenius Kabi Deutschland GmbH Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.6.4 Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.6.5 Fresenius Kabi Deutschland GmbH Recent Developments
- 12.7 Centurion Healthcare Private Limited
- 12.7.1 Centurion Healthcare Private Limited Company Information
- 12.7.2 Centurion Healthcare Private Limited Business Overview
- 12.7.3 Centurion Healthcare Private Limited Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.7.4 Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.7.5 Centurion Healthcare Private Limited Recent Developments
- 12.8 B.Braun Melsungen AG
- 12.8.1 B.Braun Melsungen AG Company Information
- 12.8.2 B.Braun Melsungen AG Business Overview
- 12.8.3 B.Braun Melsungen AG Revenue in Propofol Medium/Long Chain Fat Emulsion Injection Business (2021-2026)
- 12.8.4 B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
- 12.8.5 B.Braun Melsungen AG Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst